中国临床药学杂志

参考文献

[1]Kuroko Y,Fujii T,Yamazaki T,et a1.Contribution of catechol O-methyltransferase to the removal of accumulated interstitial cate-cholamines evoked by myocardial ischemia[J].Neurosci Lett,2005,388(2):61.

[2]Kurz T,Offner B,Schreieck J,et a1.Nonexocytotic noradrenaline re-lease and ventricular fibrillation in ischemic rat hearts[J].NaunynSchmiedebergs Arch Pharmacol,1995,352(5):491.

[3]Du XJ,Riemersma RA,Fox KA,et a1.Propranolol and lidocaineinhibit neural norepinephrine release in hearts with increased extracellu-lar potassium and ischemia[J].Circulation,1993,88(4 Pt 1):1885.

[4]Burgdorf C,Richardt D,Kurz T,et a1.Adenosine inhibits nore-pinephrine release in the postischemic rat heart:the mechanism of neu-ronal stunning[J].Cardiovasc Res,2001,49(4):713.

[5]Richardt D,Wolfrum S,Btütner C,et a1.Effect of ACE-inhibitorramiprilat and AT1-receptor antagonist candesartan on cardiac nore-pinephrine release:comparison between ischemic and nonischemic con-ditions[J].J Cardiovasc Pharmacol,2002,40(4):641.

[6]Xiao XH,Allen DG.The role of endogenous angiotensinⅡin ischemia,reperfusion and preconditioning of the isolated rat heart[J].PflugersArch,2003,445(6):643.

[7]Cox SL,Schelb V,Trendelenburg AU,et a1.Enhancement of nora-drenalme release by angiotensinⅡand bradykmin in mouse atria:evi-dence for cross-talk between G(q/11)protein and G(i/o)protein-coupledreceptors[J].Br J Pharmaco1,2000,129(6):1095.

[8]Maseroel B,Pochet L,Laeckmann D.An overview of inhibitors of Na(+)/H(+)exchanger[J].Eur J Med Chem,2003,38(6):547.

[9]Silver RB,Poonwasi KS,Seyedi N,et a1.Decreased intracellular calci-um mediates the histamine H3-receptor-induced attenuation of nore-pinephrine exocytosis from cardiac sympathetic nerve endings[J].ProcNatl Acad Sci USA,2002,99(1):501.

[10]Kurz T,Richardt D,G rge B,et a1.Differential effects of carvedilol onnorepinephrine release in normoxic and ischemic heart[J].J CardiovascPharmacol,2000,36(1):96.

[11]Richardt D,Wolfrum S,Büttner C,et a1.Effect of ACE-inhibitorramiprilat and AT1-receptor antagonist candesartan on norepinephrinerelease:comparison between ischemic and nonisehemic conditions[J].JCardiovasc Pharmacol,2002,40(4):641.

[12]马建群,毛焕元,曹林生,等.颅痛定对心肌缺血再灌注性室性心律失常及血浆去甲肾上腺素浓度的影响[J].中国实用内科杂志,2002,22(8):485.

[13]王德全,张彦周.蝙蝠葛碱对缺血心肌去甲肾上腺素释放和再灌注性室颤的影响[J].中原医刊,2004,31(9):15.

[14]王裕勤,段世英,冯义柏.缬沙坦对豚鼠心肌缺血时去甲肾上腺素释放的影响[J].华中医学杂志,2005,29(5):349.

[15]姚峰,吕云霞,张彦周,等.卡维地洛与比索洛尔对豚鼠缺血再灌注心室颤动的影响[J].郑州大学学报(医学版),2006,41(6):1080.